Risk factors
Talphera (TLPH) risk factors
Item 1A of every Talphera, Inc. 10-K on file, and what changed from one year to the next.
- FY2025 10-K risk factors
57 risks, 2 new, 6 dropped, 7 reworded since the prior year. Alora stopped non-DoD sales of DSUVIA and requested NDA withdrawal, threatening destruction of remaining inventory without DoD orders. Nasdaq issued a minimum bid price deficiency notice on March 11, 2026, threatening delisting.
Filed Mar 23, 2026 - FY2024 10-K risk factors
61 risks. Talpher operates as a clinical-stage biopharmaceutical and medical device company facing going-concern doubts.
Filed Mar 31, 2025